Published in Transplantation on July 01, 1990
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09
New immunosuppressive drugs: needs in and applications to pediatric transplantation. Eur J Pediatr (1992) 0.75
The quality of life of patients with end-stage renal disease. N Engl J Med (1985) 5.10
Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet (1971) 2.64
Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int (1997) 2.54
Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR. J Immunol (1983) 2.25
Effect of vagotomy in Zollinger-Ellison syndrome. Gastroenterology (1979) 1.81
Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am J Transplant (2008) 1.81
Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate. Kidney Int (1973) 1.80
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. Transplantation (1994) 1.80
Review and recommendations for zero-inflated count regression modeling of dental caries indices in epidemiological studies. Caries Res (2012) 1.66
Readmission to the intensive care unit after liver transplantation. Crit Care Med (2001) 1.54
Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem (1997) 1.52
Living kidney donation: a survey of professional attitudes and practices. Am J Kidney Dis (1997) 1.47
De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact. Liver Transpl Surg (1998) 1.42
The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation (1992) 1.41
The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation (1990) 1.37
Surgical treatment of diabetic nephropathy with simultaneous pancreatic duodenal and renal transplantation. Surg Gynecol Obstet (1986) 1.35
Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole. Clin Pharmacol Ther (1999) 1.32
Drug substitution in transplantation: a National Kidney Foundation White Paper. Am J Kidney Dis (1999) 1.29
Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest (1980) 1.24
All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma. J Immunol (1986) 1.19
Relationship between cytomegalovirus and hepatic function abnormalities in the period after renal transplant. J Infect Dis (1974) 1.18
Prospective comparative study of variable dosage and variable frequency regimens for administration of gentamicin. Antimicrob Agents Chemother (1975) 1.16
The elderly liver transplant recipient: a call for caution. Ann Surg (2001) 1.15
Differential expression of Ia molecules by human monocytes. J Clin Invest (1984) 1.15
Results after liver retransplantation (RETx): a comparative study between "elective" vs "nonelective" RETx. Transplant Proc (1990) 1.14
RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection. Ann Surg (1992) 1.11
Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation (2000) 1.10
Rhabdomyolysis and shock after intravenous amphetamine administration. Ann Intern Med (1977) 1.10
Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation (1997) 1.10
Hepatic artery stenosis after liver transplantation--incidence, presentation, treatment, and long term outcome. Transplantation (1997) 1.09
The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet (1993) 1.08
Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase. Growth Factors (1990) 1.07
Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation (1996) 1.05
Jejunal and ileal absorption in patients with chronic renal disease. Effect of 1alpha-hydroxycholecalciferol. J Clin Invest (1976) 1.03
Blue nevus and melanosis of prostate. J Urol (1974) 1.02
Spectrum of liver disease in renal transplant recipients. Gastroenterology (1975) 1.02
Erythromycin and cyclosporine. Transplantation (1986) 1.01
Early enteral nutrition support in patients undergoing liver transplantation. JPEN J Parenter Enteral Nutr (1996) 1.01
Combined liver-kidney transplantation: what are the indications? Transplantation (1997) 1.00
Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl (2000) 1.00
Human-Ir genes: structure and function. Adv Immunol (1983) 1.00
Probable Mycobacterium fortuitum septicemia: complication of home dialysis. Lancet (1971) 0.99
Urologic complications in 505 renal transplants with early catheter removal. J Urol (1983) 0.98
Expression of HLA-DR by a human monocyte cell line is under transcriptional control. J Mol Cell Immunol (1984) 0.98
A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation (1990) 0.96
Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation (1998) 0.96
Magnesium absorption in the human small intestine. Results in normal subjects, patients with chronic renal disease, and patients with absorptive hypercalciuria. J Clin Invest (1976) 0.95
Hyperglucagonemia in uremia: reversal by renal transplantation. Ann Intern Med (1975) 0.95
Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. Transplantation (1992) 0.95
Gamma interferon and 5-azacytidine cause transcriptional elevation of class I major histocompatibility complex gene expression in K562 leukemia cells in the absence of differentiation. Mol Cell Biol (1986) 0.94
Liver and kidney transplantation for polycystic disease. Transplantation (1998) 0.94
De novo malignancy following liver transplantation: a single-center study. Transplant Proc (1993) 0.93
Analgesic nephropathy and urinary-tract carcinoma. Ann Intern Med (1979) 0.93
Alcohol use following liver transplantation for alcoholic cirrhosis. Transplantation (1996) 0.92
Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone: regulation by interleukin-1. J Bone Miner Res (1991) 0.92
Efficacy of a Novel Nematicidal Seed Treatment against Meloidogyne incognita on Cotton. J Nematol (2006) 0.92
Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. Transplant Proc (1993) 0.91
Cannulation of the aorta in organ donors with aortic and caval injuries at the time of procurement. Pediatr Transplant (2001) 0.91
Epidemic renal transplant rejection associated with influenza A victoria. Proc Clin Dial Transplant Forum (1979) 0.90
Iatrogenic arteriovenous fistula. An unusual complication of indwelling pericardial catheter and intrapericardial steroid instillation for the treatment of uremic pericarditis. Arch Intern Med (1978) 0.89
Effect of selective proximal vagotomy on food-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer. Gastroenterology (1979) 0.89
Disease due to cytomegalovirus and its long-term consequences in renal transplant recipients. Correlation of allograft survival with disease due to cytomegalovirus and rubella antibody level. Arch Intern Med (1983) 0.89
Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome. Semin Liver Dis (1992) 0.88
Failure of cyclosporine to prevent in vivo T cell priming in man. Studies in allogeneic spleen transplantation. Transplantation (1985) 0.88
Surgical management of severe acute pancreatitis. Arch Surg (1982) 0.88
Rejection in liver transplantation. Hepatology (1989) 0.87
Does intraoperative hepatic artery flow predict arterial complications after liver transplantation? Transplantation (1998) 0.87
Treatment of Zollinger-Ellison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonists. A prospective study. Gastroenterology (1985) 0.87
Metabolic effects of urinary diversion of exocrine secretions in pancreatic transplantation. Transplantation (1987) 0.87
Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant. Transplantation (1997) 0.86
Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy. Am J Transplant (2008) 0.86
Jejunal absorption and secretion of calcium in patients with chronic renal disease on hemodialysis. J Clin Invest (1974) 0.86
The kidney in liver transplantation. J Am Soc Nephrol (1993) 0.86
Quality of life improvements at one, two, and five years after liver transplantation. Transplantation (1995) 0.86
The legislative and regulatory process in the end-stage renal disease (ESRD) program, 1973 through 1997. Semin Nephrol (1997) 0.86
The control of hypertension in patients undergoing regular maintenance hemodialysis. Kidney Int Suppl (1975) 0.85
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. Transplant Proc (1995) 0.85
Baylor update: outcome analysis in liver transplantation. Clin Transpl (1993) 0.85
Etiology of liver disease in renal-transplant patients. Ann Intern Med (1979) 0.85
Survival after liver transplantation in 300 consecutive patients: the influence of age, clinical status, and pretransplant disease. Transplant Proc (1992) 0.85
Renal transplantation with cyclosporine in the elderly population. Transplant Proc (1991) 0.85
The safety of cardiac operations in the liver transplant recipient. Ann Thorac Surg (1998) 0.85
Comparison of an enzyme-linked immunospecific assay (ELISA) with the cold complement fixation test for the serodiagnosis of Brucella ovis infection. N Z Vet J (2005) 0.84
Recovery from malignant hypertension with anuria after prolonged hemodialysis. South Med J (1976) 0.84
Dallas experience with cyclosporine A (CsA) one to six months posttransplant. Transplant Proc (1986) 0.84
Suppression of interferon response in lymphocytes from patients with uremia. J Lab Clin Med (1971) 0.82
Colon carcinoma in patients undergoing liver transplantation. Am J Surg (1998) 0.82
Minimum steroid requirements in the late post-transplant period. Transplant Proc (1975) 0.82